{
  "ticker": "JNJ",
  "target_date": "2025-09-26",
  "actual_date": "2025-09-26",
  "collected_at": "2025-12-08T12:19:52.841202",
  "price": {
    "open": 177.47,
    "high": 178.77,
    "low": 176.2,
    "close": 178.57618713378906,
    "volume": 8634400,
    "change_1d_pct": 1.11,
    "change_7d_pct": 1.42,
    "change_30d_pct": 3.61
  },
  "technicals": {
    "rsi_14": 53.88,
    "sma_20": 176.09,
    "sma_50": 172.4,
    "macd": 1.089,
    "macd_signal": 1.289,
    "macd_histogram": -0.2,
    "bb_upper": 178.89,
    "bb_lower": 173.29,
    "price_vs_sma20_pct": 1.41,
    "price_vs_sma50_pct": 3.58,
    "volume_ratio": 1.03
  },
  "fundamentals": {
    "market_cap": 487569031168,
    "pe_ratio": 19.533785,
    "forward_pe": 19.091509,
    "price_to_book": 6.142289,
    "price_to_sales": 5.2910943,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.62,
    "pct_from_52w_low": 43.85
  },
  "macro": {
    "spy": {
      "price": 661.82,
      "change_1d_pct": 0.57,
      "change_7d_pct": 0.21
    },
    "vix": {
      "level": 15.29,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.19
    },
    "dollar_index": {
      "level": 98.15
    },
    "gold": {
      "price": 3775.3
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing",
      "source": "Yahoo",
      "datetime": 1758923103,
      "summary": "Johnson & Johnson (JNJ) closed at $179.71 in the latest trading session, marking a +1.11% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=e917a8e83a152e7bdfc518fcc2ad2a1f05bd1ef60d9fb0358f88f9b89f835f8e"
    },
    {
      "headline": "Has AbbVie Successfully Navigated Top-line Growth Post Humira LOE?",
      "source": "Yahoo",
      "datetime": 1758901500,
      "summary": "ABBV eyes a 2025 rebound as Skyrizi and Rinvoq drive growth beyond Humira, with oncology and neuroscience adding momentum.",
      "url": "https://finnhub.io/api/news?id=f94823b0b710280a05310f850e35629c0191f2798fbdc1ec587b9d079aefbf90"
    },
    {
      "headline": "Trump's new tariffs on pharma, furniture, & trucks: What to know",
      "source": "Yahoo",
      "datetime": 1758895101,
      "summary": "President Trump announced sweeping new tariffs on pharmaceuticals, heavy trucks, and furniture imports. The duty on pharmaceuticals sits at 100% for patented drugs unless the producer is building a manufacturing plant in the US. White House columnist for The Hill, Niall Stanage, and Yahoo Finance se",
      "url": "https://finnhub.io/api/news?id=d7991ae95fc41cdc2d33538ff9b6e84b21dd938423a6bbf5b5aea179b58efa25"
    },
    {
      "headline": "Big pharma stocks rise as Street reacts to latest presidential tariff plan",
      "source": "Yahoo",
      "datetime": 1758892447,
      "summary": "Shares of some big drugmakers jumped ahead of broader indexes Friday as Wall Street started sorting out President Donald Trump\u2019s latest tariff announcement.  The president said late Thursday that he would place 100% import taxes on pharmaceuticals starting Oct. 1, but those tariffs would not apply t",
      "url": "https://finnhub.io/api/news?id=4b37a7be94a8687633bc24664a4565f06a7e6f2105839c6b4d6ce3ced85e7422"
    },
    {
      "headline": "Jim Cramer Discusses Kenvue Inc. (KVUE) & Legal Issues",
      "source": "Yahoo",
      "datetime": 1758891308,
      "summary": "We recently published 14 Stocks Jim Cramer Discussed Including His 2 Top Quantum Computing Stocks. Kenvue Inc. (NYSE:KVUE) is one of the stocks Jim Cramer recently discussed. Kenvue Inc. (NYSE:KVUE) has been in the news lately after President Trump asserted that taking Tylenol can increase autism in",
      "url": "https://finnhub.io/api/news?id=b26b4083724726f5a45ef84db7e39ee1d22ad69f63ba5ebbf3cb6fdfe734ad13"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627206.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000192/xslF345X05/wk-form4_1757627206.xml"
    },
    {
      "form": "8-K",
      "date": "2025-09-09",
      "description": "jnj-20250908.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"
    },
    {
      "form": "4",
      "date": "2025-09-05",
      "description": "xslF345X05/wk-form4_1757109644.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}